Lupsingen, Switzerland

Ralph O Schoenleber

This inventor holds 5 USPTO granted patents and 3 published patent applications. Top assignee: Bachem Holding Ag. Active years: 2020-2026.

USPTO Granted Patents = 5 

% Patents Active = 100.0

Average Co-Inventor Count = 3.3

ph-index = 1


Company Filing History:


Years Active: 2020-2026

Loading Chart...
5 patents (USPTO):Explore Patents

Title: **Ralph O. Schoenleber: Innovator in Peptide Synthesis**

Introduction

Ralph O. Schoenleber is a notable inventor based in Lupsingen, Switzerland, with a focus on advancements in peptide synthesis. With three patents to his name, he has made significant contributions to the field of biochemistry, especially in the development of methods for synthesizing complex peptides.

Latest Patents

Among his notable inventions, two stand out for their relevance in modern scientific applications. The first is the patent for the **Solid Phase Synthesis of Acylated Peptides**, which presents innovative techniques for synthesizing peptides that carry specific substituents at the amino groups of amino acid side chains. This method enhances the ability to create tailored peptides for pharmaceutical and research purposes.

The second patent, **Method for Preparing Glucagon-like Peptides**, describes a method for synthesizing glucagon-like peptides, integrating the use of anti-solvents such as diisopropyl ether and acetonitrile to precipitate the desired peptides. This invention also includes details on creating peptide conjugates and pharmaceutical compositions, including options for Liraglutide peptides.

Career Highlights

Ralph O. Schoenleber has built his career at Bachem Holding AG, a leading company in the field of peptide and organic synthesis. His work not only highlights the innovative processes he developed but also emphasizes the applications of these methods in creating peptide therapeutics, which are vital in modern medicine.

Collaborations

Throughout his career, Schoenleber has worked alongside esteemed colleagues such as Guenther Loidl and Andreas Stadelmaier. Their collaboration has likely contributed to advancing the research and development of peptides, further enhancing the output and quality of their work at Bachem Holding AG.

Conclusion

Ralph O. Schoenleber represents a key figure in the world of peptide synthesis, with his patented methods facilitating groundbreaking work in biochemistry and pharmaceuticals. As his contributions continue to influence the field, he stands as a testament to the impact of innovation in scientific research and development.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…